LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
I asked ChatGPT for the best UK stocks for me to buy for 2025. Here are 5 names it gave me
Investing Articles
If the market shut down for 10 years, I’d be happy to hold these 2 FTSE 100 shares
Investing Articles
Analysts are saying the AstraZeneca share price looks cheap despite China turmoil
Investing For Beginners
Something big just happened in the UK stock market
Investing Articles
5 simple steps for targeting a £1,000,000 SIPP
Investing Articles
Down 20% in 14 weeks, is AstraZeneca’s share price now too big a bargain for me to miss?
Investing Articles
Where might the AstraZeneca share price go in 2025? Here’s what the experts forecast
Growth Shares
Directors at this FTSE 100 company just bought over £2m worth of shares
Investing Articles
2 top shares I’ve bought for my Stocks and Shares ISA in November
Investing Articles
What on earth is going on with the AstraZeneca share price?
Growth Shares
The AstraZeneca share price just fell 8.4% in a day. Is it time to consider buying?